1. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension
   Veronika Wetzl et al, 2017, Lung CrossRef
2. (±)-Japonicols A–D, Acylphloroglucinol-Based Meroterpenoid Enantiomers with Anti-KSHV Activities from Hypericum japonicum
   Linzhen Hu et al, 2016, Journal of Natural Products CrossRef
3. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension
   Vijaya Karoor et al, 2021, International Journal of Molecular Sciences CrossRef
4. Fluoxetine protects against methamphetamine-induced lung inflammation by suppressing oxidative stress through the SERT/p38 MAPK/Nrf2 pathway in rats
   Yun Wang et al, 2017, Molecular Medicine Reports CrossRef
5. PCPA protects against monocrotaline-induced pulmonary arterial remodeling in rats: potential roles of connective tissue growth factor
   Yang Bai et al, 2017, Oncotarget CrossRef
6. Serotonin stimulates Echinococcus multilocularis larval development
   Michaela Herz et al, 2021, Parasites & Vectors CrossRef
7. Phenylalanine induces pulmonary hypertension through calcium-sensing receptor activation
   Rubin Tan et al, 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
8. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis
   Junhua Xu et al, 2022, Journal of Hypertension CrossRef
9. Inhibitory effects of formononetin on the monocrotaline‑induced pulmonary arterial hypertension in rats
   Yonghui Wu et al, 2020, Molecular Medicine Reports CrossRef
10. The role of serotonin and its receptors in activation of immune responses and inflammation
    M. S. Shajib et al, 2015, Acta Physiologica CrossRef
11. AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats
    Yi Hu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
12. Expression of apoptotic proteins in the pulmonary artery of dogs with pulmonary hypertension secondary to degenerative mitral valve disease
    Siriwan Sakarin et al, 2022, Research in Veterinary Science CrossRef
13. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB
    Yang Bai et al, 2017, International Journal of Molecular Medicine CrossRef
14. Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study
    Nattawan Tangmahakul et al, 2022, Veterinary Sciences CrossRef
15. The TIMP protein family: diverse roles in pathophysiology
    Sasha Coates-Park et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
16. The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease
    Siriwan Sakarin et al, 2020, Frontiers in Veterinary Science CrossRef
17. Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
    Haihua Qiu et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
18. Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease
    Siriwan Sakarin et al, 2023, Veterinary Research Communications CrossRef